Type i DNA topoisomerases

G Capranico, J Marinello… - Journal of medicinal …, 2017 - ACS Publications
DNA topoisomerases constitute a large family of enzymes that are essential for all domains
of life. Although they share general reaction chemistry and the capacity to govern DNA …

Anthraquinone: a promising scaffold for the discovery and development of therapeutic agents in cancer therapy

S Siddamurthi, G Gutti, S Jana, A Kumar… - Future medicinal …, 2020 - Taylor & Francis
Cancer, characterized by uncontrolled malignant neoplasm, is a leading cause of death in
both advanced and emerging countries. Although, ample drugs are accessible in the market …

Natural compounds as anticancer agents targeting DNA topoisomerases

C Kumar Jain, H Kumar Majumder… - Current …, 2017 - ingentaconnect.com
DNA topoisomerases are important cellular enzymes found in almost all types of living cells
(eukaryotic and prokaryotic). These enzymes are essential for various DNA metabolic …

Discovery of novel polycyclic heterocyclic derivatives from evodiamine for the potential treatment of triple-negative breast cancer

S Xu, H Yao, Y Qiu, M Zhou, D Li, L Wu… - Journal of Medicinal …, 2021 - ACS Publications
Evodiamine (Evo) is a quinazolinocarboline alkaloid found in Evodia rutaecarpa and
exhibits moderate antiproliferative activity. Herein, we report using a scaffold-hopping …

Pterocarpan scaffold: A natural lead molecule with diverse pharmacological properties

C Selvam, BC Jordan, S Prakash, D Mutisya… - European Journal of …, 2017 - Elsevier
Phytoalexins are substances produced by plants that act as potent inhibitors of pathogens.
Pterocarpans are biologically active isoflavonoids most commonly found in the family …

Advances in the chemistry of natural and semisynthetic topoisomerase I/II inhibitors

VA D'yakonov, LU Dzhemileva… - Studies in natural products …, 2017 - Elsevier
The search for new, effective, and low-toxic anticancer agents is one of the most important
tasks of modern medicinal chemistry. In general, the solution to this problem comes down to …

Topoisomerase IIα, rather than IIβ, is a promising target in development of anti-cancer drugs

W Chen, J Qiu, Y Shen - Drug discoveries & therapeutics, 2012 - jstage.jst.go.jp
DNA topoisomerase II (TOP2) is a wellknown anticancer target. Its inhibitors are among the
most effective anticancer drugs currently in clinical use. TOP2-targeting agents fall into two …

Natural products as new antimitotic compounds for anticancer drug development

CRK Paier, SSA Maranhão, TR Carneiro, LM Lima… - Clinics, 2018 - SciELO Brasil
Cell cycle control genes are frequently mutated in cancer cells, which usually display higher
rates of proliferation than normal cells. Dysregulated mitosis leads to genomic instability …

Effect of oxindolimine copper(ii) and zinc(ii) complexes on human topoisomerase I activity

P Katkar, A Coletta, S Castelli, GL Sabino… - Metallomics, 2014 - academic.oup.com
The ability of oxindolimine copper (ii) and zinc (ii) complexes, known to have antitumor
activity, to inhibit human topoisomerase IB has been tested through enzymatic kinetic assays …

[HTML][HTML] Topoisomerase IB: a relaxing enzyme for stressed DNA

BC Soren, JB Dasari, A Ottaviani, F Iacovelli… - Cancer Drug …, 2020 - ncbi.nlm.nih.gov
DNA topoisomerase I enzymes relieve the torsional strain in DNA; they are essential for
fundamental molecular processes such as DNA replication, transcription, recombination …